BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9510558)

  • 1. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.
    Kobayashi H; Kokubo T; Takahashi M; Sato K; Miyokawa N; Kimura S; Kinouchi R; Katagiri M
    Immunogenetics; 1998 Apr; 47(5):398-403. PubMed ID: 9510558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
    Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.
    Gocho K; Kondo I; Yamaki K
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2004-9. PubMed ID: 11481264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of binding of putative antigenic peptides to HLA-DRB1 alleles in Vogt-Koyanagi-Harada disease.
    Prasad PS; Levinson RD
    Clin Immunol; 2005 Aug; 116(2):143-8. PubMed ID: 15927531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease.
    Sugita S; Takase H; Kawaguchi T; Taguchi C; Mochizuki M
    Int Ophthalmol; 2007; 27(2-3):87-95. PubMed ID: 17253112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
    Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of anchor residues in a naturally processed HLA-DR53 ligand.
    Kobayashi H; Kokubo T; Abe Y; Sato K; Kimura S; Miyokawa N; Katagiri M
    Immunogenetics; 1996; 44(5):366-71. PubMed ID: 8781122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
    Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
    Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
    Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
    Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.
    Yamaki K; Gocho K; Hayakawa K; Kondo I; Sakuragi S
    J Immunol; 2000 Dec; 165(12):7323-9. PubMed ID: 11120868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase.
    Kobayashi H; Kokubo T; Sato K; Kimura S; Asano K; Takahashi H; Iizuka H; Miyokawa N; Katagiri M
    Cancer Res; 1998 Jan; 58(2):296-301. PubMed ID: 9443408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
    Wucherpfennig KW; Yu B; Bhol K; Monos DS; Argyris E; Karr RW; Ahmed AR; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11935-9. PubMed ID: 8524878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.
    Kittlesen DJ; Thompson LW; Gulden PH; Skipper JC; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL
    J Immunol; 1998 Mar; 160(5):2099-106. PubMed ID: 9498746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens].
    Sugita S
    Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):953-64. PubMed ID: 19069378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.
    Shindo Y; Inoko H; Yamamoto T; Ohno S
    Br J Ophthalmol; 1994 Mar; 78(3):223-6. PubMed ID: 7908535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease.
    Alaez C; del Pilar Mora M; Arellanes L; Cano S; Perez-Luque E; Vazquez MN; Olivo A; Burguete A; Hernandez A; Pedroza M; Gorodezky C
    Hum Immunol; 1999 Sep; 60(9):875-82. PubMed ID: 10527396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.